Walgreens Boots Alliance third-quarter profit beats amid take-private deal

Published 26/06/2025, 12:22
© Reuters

Investing.com - Walgreens Boots Alliance (NASDAQ:WBA) posted third-quarter earnings and sales that topped estimates, as cost savings helped to offset front-end sales at the likely soon-to-be private retail pharmacy chain.

The second-largest U.S. pharmacy did not provide financial guidance given its impending takeover by private-equity firm Sycamore Parners.

In March, the two agreed to a $10 billion deal that will see Sycamore take Walgreens private, ending nearly a century of public trading. The transaction is anticipated to close in the third or fourth quarter of the 2025 calendar year, pending shareholder and regulatory approval.

Once complete, Walgreens will be delisted from the Nasdaq.

Walgreens was once worth $100 billion a decade ago, but declining drug margins and intense competition from rivals like Walmart (NYSE:WMT) and Amazon (NASDAQ:AMZN) for shoppers looking to fill prescriptions and pick up cheaper toiletries have weighed on the business.

Under CEO Tim Wentworth, Walgreens has been shuttering thousands of stores in a bid to cut expenses by $1 billion.

Adjusted earnings per share during the period came in at $0.38, down from $0.63 in the year-ago quarter but above Bloomberg consensus estimates of $0.31.

Group-wide sales increased by 7.2% year-on-year to $39 billion, versus analysts’ projections of $36.79 billion.

Shares of Walgreens were slightly higher in premarket U.S. trading on Thursday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.